Park Square has placed Reza Afkhami as Chief Corporate Development Officer at 23andMe.
23andMe Holding Co. (Nasdaq: ME) ("23andMe"), a leading human genetics and biopharmaceutical company, today announced the appointment of Reza Afkhami as its Chief Corporate Development Officer overseeing corporate development efforts across its therapeutics, research services and consumer groups.
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search
